MedPath

Verapamil Hydrochloride

VERAPAMIL HCl EXTENDED-RELEASE TABLETS USPRx only

Approved
Approval ID

887b91f5-f117-47e6-8d59-87ac61d17175

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 20, 2010

Manufacturers
FDA

Blenheim Pharmacal, Inc.

DUNS: 171434587

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Verapamil Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code10544-541
Application NumberANDA073568
Product Classification
M
Marketing Category
C73584
G
Generic Name
Verapamil Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateAugust 20, 2010
FDA Product Classification

INGREDIENTS (10)

VERAPAMIL HYDROCHLORIDEActive
Quantity: 240 mg in 1 1
Code: V3888OEY5R
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
HYPROMELLOSEInactive
Code: 3NXW29V3WO
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
HYDROXYPROPYL CELLULOSEInactive
Code: RFW2ET671P
Classification: IACT
SODIUM ALGINATEInactive
Code: C269C4G2ZQ
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
POLYETHYLENE GLYCOLInactive
Code: 3WJQ0SDW1A
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Verapamil Hydrochloride - FDA Drug Approval Details